Yin Xiu-Wen, Hu Jun-Jie, Ren Fu-Cai, Pu Xiang-Dong, Yang Meng-Yu, Yang Bing-Yuan, Wang Peng, Shen Chuan-Pu
Anhui Provincial Laboratory of Inflammatory and Immunity Disease, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, People's Republic of China.
Guangxi Key Laboratory of Plant Functional Phytochemicals and Sustainable Utilization, Guangxi Institute of Botany, Guangxi Zhuang Autonomous Region and Chinese Academy of Sciences, Guilin 541006, People's Republic of China.
ACS Omega. 2024 Aug 2;9(32):34869-34879. doi: 10.1021/acsomega.4c04403. eCollection 2024 Aug 13.
In this study, eight lindenane-type sesquiterpene dimers, including five previously undescribed sesquiterpene dimers (-), were isolated from the roots of , and their structures were elucidated using 1D/2D NMR, HRESIMS, and ECD calculations. Compound presents the second example of a type of novel 8,9- lindenane-type sesquiterpene dimer, considered a product of 8/9-diketone oxidation. Compounds and represent the third and fourth examples, respectively, of this kind of C-11 methine dimer. Furthermore, compound was considered as an artifact generated from the radical reaction of a known compound chlojaponilide F (), which was explained by the density functional theory quantum calculation. All isolates were evaluated for their protective activity against the LPS-induced pulmonary epithelial cell line with compound exhibiting the most potent bioactivity. Further biological evaluation demonstrated that reduced the production of reactive oxygen species and interleukin-1β, further regulated by the expression of the NLRP3. These results show that compound exhibits therapeutic potential for lung inflammatory diseases.
在本研究中,从[植物名称]的根中分离出8种椴烷型倍半萜二聚体,其中包括5种先前未描述的倍半萜二聚体(-),并使用1D/2D NMR、HRESIMS和ECD计算对其结构进行了阐明。化合物[具体化合物编号]是一种新型8,9-椴烷型倍半萜二聚体的第二个实例,被认为是8/9-二酮氧化的产物。化合物[具体化合物编号]和[具体化合物编号]分别是这种C-11次甲基二聚体的第三个和第四个实例。此外,化合物[具体化合物编号]被认为是由已知化合物氯杂环戊烯酮F([具体结构])的自由基反应产生的假象,这一点通过密度泛函理论量子计算得到了解释。对所有分离物进行了针对LPS诱导的肺上皮细胞系的保护活性评估,化合物[具体化合物编号]表现出最强的生物活性。进一步的生物学评估表明,[具体化合物编号]减少了活性氧和白细胞介素-1β的产生,并进一步受到NLRP3表达的调节。这些结果表明,化合物[具体化合物编号]对肺部炎症性疾病具有治疗潜力。